Additive effects of TRAIL and paclitaxel on cancer cells: implications for advances in cancer therapy. (Q35756912)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110187%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

review article

1 reference

title

Additive effects of TRAIL and paclitaxel on cancer cells: implications for advances in cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110187%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110187%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Christine Odoux

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110187%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110187%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

published in

Vitamins and Hormones

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110187%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110187%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

385-407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110187%20AND%20SRC:MED&resulttype=core&format=json

Human ICE/CED-3 protease nomenclature

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Paclitaxel and docetaxel combinations in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Paclitaxel-induced FasL-independent apoptosis and slow (non-apoptotic) cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Two-step formation of 1H NMR visible mobile lipids during apoptosis of paclitaxel-treated K562 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

New combinations in the treatment of lung cancer: a time for optimism

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

High-dose chemotherapy in adult patients with germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Phase II Trial of Taxol in Patients with Metastatic Renal Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

The TRAIL to selective tumor death

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inh

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Signal transduction pathways of taxanes-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Caspase-8 activation independent of CD95/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4).

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

TRAIL: a molecule with multiple receptors and control mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Altered expression of M beta 2, the class II beta-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Current clinical practices for ovarian cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome C and caspase-3 activity during Taxol-induced apoptosis of human AML HL-60 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Inhibition of death receptor signals by cellular FLIP

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Action of taxol on mitosis: modification of microtubule arrangements and function of the mitotic spindle in Haemanthus endosperm

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Tumor necrosis factor as an antineoplastic agent: pitfalls and promises

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Taxane/anthracycline combinations: setting a new standard in breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

European perspectives on paclitaxel/platinum-based therapy for advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

TRAIL, Fasl and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Taxol-induced apoptosis in human SKOV3 ovarian and MCF7 breast carcinoma cells is caspase-3 and caspase-9 independent

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

A crucial role of caspase 3 and caspase 8 in paclitaxel-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Doxorubicin and paclitaxel in the treatment of advanced breast cancer: efficacy and cardiac considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Paclitaxel induces apoptosis in Saos-2 cells with CD95L upregulation and Bcl-2 phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Characterization of the taxol binding site on the microtubule. 2-(m-Azidobenzoyl)taxol photolabels a peptide (amino acids 217-231) of beta-tubulin

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Predicting response to paclitaxel/carboplatin-based therapy in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Taxol: a novel investigational antimicrotubule agent

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Apoptosis induced by low-dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Effect of taxol on secretory cells: functional, morphological, and electrophysiological correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Trail activity in human ovarian cancer cells: potentiation of the action of cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Paclitaxel-induced apoptosis in human ovarian cancer cell line COC1

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Paclitaxel-induced apoptosis in non-small cell lung cancer cell lines is associated with increased caspase-3 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Taxol induces tyrosine phosphorylation of Shc and its association with Grb2 in murine RAW 264.7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

Paclitaxel induces apoptosis in human gastric carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967020-8

7 January 2021

10.1016/S0083-6729(04)67020-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110187%20AND%20SRC:MED&resulttype=core&format=json

release_2kk54woowrbg3k56a3l6jrerle

27 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2kk54woowrbg3k56a3l6jrerle

24 November 2022

mapped directly with Wikidata item

1 reference